﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Infectious Diseases in Obstetrics and Gynecology</title><link>http://www.hindawi.com</link><description>The latest articles from Hindawi Publishing Corporation</description><copyright>&amp;#169; 2012, Hindawi Publishing Corporation. All rights reserved.</copyright><item><title>The Prevalence of Urogenital Infections in Pregnant Women Experiencing Preterm and Full-Term Labor</title><link>http://www.hindawi.com/journals/idog/2012/878241/</link><description>Urogenital infections are extremely prevalent during pregnancy and are an important cause of premature labor. However, the prevalence of urogenital infections during childbirth is not well known. Objective. Identify urogenital infections present at the beginning of labor in both full-term and preterm pregnancies. Study Design. Ninety-four women were admitted to the inpatient maternity clinic of the Federal University of Rio Grande do Norte (UFRN). In total, 49 women in preterm labor and 45 women in full-term labor were included in the study, and samples of urinary, vaginal, and perianal material were collected for microbiological analysis. Results. The prevalences of general infections in the preterm labor group and the full-term labor group were 49.0% and 53.3% (P=0.8300), respectively. Urogenital infections in the preterm and full-term labor groups included urinary tract infection in 36.7% and 22.2% of women, vaginal candidiasis in 20.4% and 28.9% of women, bacterial vaginosis in 34.7% and 28.9% of women, and group B streptococcus in 6.1% and 15.6% of women, respectively. Conclusions. Urogenital infections were prevalent in women in preterm labor and full-term labor; however, significant differences between the groups were not observed.</description><Author>Paulo C&amp;#x00E9;sar Giraldo, Edilson D. Ara&amp;#x00FA;jo, Jos&amp;#x00E9; Eleut&amp;#x00E9;rio Junior, Rose Luce Gomes do Amaral, Mauro R. L. Passos, and Ana Katherine Gon&amp;#x00E7;alves</Author><copyright>Copyright &amp;#xa9; 2012 Paulo C&amp;#xe9;sar Giraldo et al. All rights reserved.</copyright></item><item><title>Maternal Vitamin D, Folate, and Polyunsaturated Fatty Acid Status and Bacterial Vaginosis during Pregnancy</title><link>http://www.hindawi.com/journals/idog/2011/216217/</link><description>Objective. To investigate associations among serum 25-hydroxy-vitamin D (25-OH-D), folate, omega-6/omega-3 fatty acid ratio and bacterial vaginosis (BV) during pregnancy. Methods. Biospecimens and data were derived from a random sample (N=160) of women from the Nashville Birth Cohort. We compared mean plasma nutrient concentrations for women with and without BV during pregnancy (based on Nugent score &amp;#x02265;7) and assessed the odds of BV for those with 25-OH-D &amp;lt;12&amp;#x2009;ng/mL, folate &amp;lt;5&amp;#x2009;ug/L, and omega-6/omega-3 ratio &amp;gt;15. Results. The mean plasma 25-OH-D was significantly lower among women with BV during pregnancy (18.00±8.14&amp;#x2009;ng/mL versus 24.34±11.97&amp;#x2009;ng/mL, P=0.044). The adjusted odds of BV were significantly increased among pregnant women with 25-OH-D &amp;lt;12&amp;#x2009;ng/mL (aOR 5.11, 95&amp;#37; CI: 1.19&amp;#8211;21.97) and folate &amp;#x0003c;5&amp;#x2009;ug/L (aOR 7.06, 95&amp;#37; CI: 1.07&amp;#8211;54.05). Conclusion. Vitamin D and folate deficiencies were strongly associated with BV (Nugent score &amp;#x02265;7) during pregnancy.</description><Author>Anne L. Dunlop, Robert N. Taylor, Vin Tangpricha, Stephen Fortunato, and Ramkumar Menon</Author><copyright>Copyright &amp;#xa9; 2011 Anne L. Dunlop et al. All rights reserved.</copyright></item><item><title>Association between Semen Exposure and Incident Bacterial Vaginosis</title><link>http://www.hindawi.com/journals/idog/2011/842652/</link><description>Objective. To identify correlates of incident bacterial vaginosis (BV) diagnosed with Nugent scoring among high-risk women. 
Study Design. We conducted both cohort and case-crossover analyses, stratified by HIV infection status, based on 871 HIV-infected and 439 HIV-uninfected participants in the HIV Epidemiology Research Study, conducted in 4 US sites in 1993&amp;#8211;2000. Results. BV incidence was 21&amp;#37; and 19&amp;#37; among HIV-infected and -uninfected women, respectively. Fewer correlates of BV were found with case-crossover than with cohort design. Reporting frequent coitus (regardless of consistency of condom use) was correlated with BV in cohort analyses but not in case-crossover analyses. The sole correlate of BV in both types of analyses was the detection of spermatozoa on Gram stain, which is a marker of semen exposure. Conclusion. The inconsistent association between condom use and BV in prior studies could be from reporting bias. We found evidence of a relationship between semen exposure and incident BV.</description><Author>Maria F. Gallo, Lee Warner, Caroline C. King, Jack D. Sobel, Robert S. Klein, Susan Cu-Uvin, Anne M. Rompalo, and Denise J. Jamieson</Author><copyright>Copyright &amp;#xa9; 2011 Maria F. Gallo et al. All rights reserved.</copyright></item><item><title>Progesterone Interactions with the Cervix: Translational Implications for Term and Preterm Birth</title><link>http://www.hindawi.com/journals/idog/2011/353297/</link><description>The uterine cervix plays a vital role in maintaining pregnancy and an equally important role in allowing parturition to occur. Progesterone, either endogenously produced or supplied exogenously, supports the function of the cervix in sustaining intrauterine pregnancy, and the withdrawal of progesterone, either through natural processes or pharmacologic intervention, leads to delivery which underscores the importance of the progesterone's biological activities manifest in normal gestation and pregnancy that ends prematurely. Research crossing many scientific disciplines has demonstrated that progesterone is a pleotropic compound that affects the cervix through cytoplasmic and membrane receptors with profound effects on cellular and molecular functions that influence inflammatory cascades and extracellular matrix, both of which have consequences for parturition. Beyond the local cell and molecular biology of progesterone, it has systemic effects of relevance to pregnancy as well. This paper examines the biology of the cervix from its gross to cellular structure and biological activities of its cell and molecular processes that may be affected by progesterone. The implications of these processes for preterm birth are explored, and direction of current research is in relation to translational medicine implications for diagnostic, prognostic, and therapeutic approaches to threatened preterm birth.</description><Author>Bryan Larsen and Joseph Hwang</Author><copyright>Copyright &amp;#xa9; 2011 Bryan Larsen and Joseph Hwang. All rights reserved.</copyright></item><item><title>Vaginal Microbiota of Healthy Pregnant Mexican Women is Constituted by Four Lactobacillus Species and  Several Vaginosis-Associated Bacteria</title><link>http://www.hindawi.com/journals/idog/2011/851485/</link><description>Objective. To identify the microbiota communities in the vaginal tracts of healthy Mexican women across the pregnancy. Methods. Vaginal swabs were obtained during the prenatal visit of women from all trimesters (n=64) of healthy pregnant women of Mexico City. DNA was isolated from each sample, and PCR-DGGE and sequencing of 16S rRNA gene fragments were used to identify the bacterial communities. Results. 21 different microorganisms were identified in the vaginal samples. Lactobacillus genus was present in 98&amp;#37; of women studied. Four lactobacilli species were identified in vaginal samples. L. acidophilus was the predominant (78&amp;#37;) followed by L. iners (54&amp;#37;), L. gasseri (20&amp;#37;), and L. delbrueckii (6&amp;#37;). 17 different microorganisms related to bacterial vaginosis conditions were identified. Ureaplasma urealyticum was the predominant (21&amp;#37;) followed by BVAB1 (17&amp;#37;) and Gemella bergeriae (7.8&amp;#37;). Conclusions. Lactobacillus genus predominates in the vaginal samples of Mexican pregnant women associated with different microorganisms related to bacterial vaginosis conditions.</description><Author>C&amp;#233;sar Hern&amp;#225;ndez-Rodr&amp;#237;guez, Roberto Romero-Gonz&amp;#225;lez, Mario Albani-Campanario, Ricardo Figueroa-Dami&amp;#225;n, Noem&amp;#237; Meraz-Cruz, and C&amp;#233;sar Hern&amp;#225;ndez-Guerrero</Author><copyright>Copyright &amp;#xa9; 2011 C&amp;#xe9;sar Hern&amp;#xe1;ndez-Rodr&amp;#xed;guez et al. All rights reserved.</copyright></item><item><title>Imiquimod 3.75&amp;#37; Cream Applied Daily to Treat Anogenital Warts: Combined Results from Women in Two Randomized, Placebo-Controlled Studies</title><link>http://www.hindawi.com/journals/idog/2011/806105/</link><description>Objective. To evaluate if new imiquimod formulations using a shorter treatment duration are safe and efficacious to treat anogenital warts. Methods. In two studies 534 women &amp;#x2265;12 years of age (mean 33.4) with 2&amp;#8211;30 warts (mean 7.9) and total wart area &amp;#x2265;10&amp;#x2009;mm2 (mean 166.3) were randomized (1&amp;#x2009;:&amp;#x2009;2&amp;#x2009;:&amp;#x2009;2) to placebo (106), imiquimod 2.5&amp;#37; (212) or 3.75&amp;#37; (216) creams applied once daily until complete clearance or a maximum of 8 weeks. Results. For placebo, imiquimod 2.5&amp;#37; and 3.75&amp;#37;, respectively, complete clearance of all warts was achieved in 14.2&amp;#37;, 28.3&amp;#37;, and 36.6&amp;#37; of women (intent-to-treat, P=0.008 imiquimod 2.5&amp;#37;, and P&amp;#x003C;0.001 3.75&amp;#37; versus placebo). Mean changes in wart counts were &amp;#x2212;10.7&amp;#37;, &amp;#x2212;50.9&amp;#37;, and &amp;#x2212;63.5&amp;#37; (per-protocol, P&amp;#x003C;0.001 each active versus placebo) and safety-related discontinuation rates 0.9&amp;#37;, 1.4&amp;#37;, and 2.3&amp;#37;. Conclusions. Imiquimod 3.75&amp;#37; applied daily for up to 8 weeks was well tolerated and superior to placebo in treating women with external anogenital warts.</description><Author>David A. Baker, Daron G. Ferris, Mark G. Martens, Kenneth H. Fife, Stephen K. Tyring, Libby Edwards, Anita Nelson, Kevin Ault, Kenneth F. Trofatter, Tiepu Liu, Sharon Levy, and Jason Wu</Author><copyright>Copyright &amp;#xa9; 2011 David A. Baker et al. All rights reserved.</copyright></item><item><title>Bacterial Vaginosis and the Natural History of Human Papillomavirus</title><link>http://www.hindawi.com/journals/idog/2011/319460/</link><description>Objective. To evaluate associations between common vaginal infections and human papillomavirus (HPV). Study Design. Data from up to 15 visits on 756 HIV-infected women and 380 high-risk HIV-uninfected women enrolled in the HIV Epidemiology Research Study (HERS) were evaluated for associations of bacterial vaginosis, trichomoniasis, and vaginal Candida colonization with prevalent HPV, incident HPV, and clearance of HPV in multivariate analysis. Results.  Bacterial vaginosis (BV) was associated with increased odds for prevalent (aOR = 1.14, 95&amp;#37; CI: 1.04, 1.26) and incident (aOR = 1.24, 95&amp;#37; CI: 1.04, 1.47) HPV and with delayed clearance of infection (aHR = 0.84, 95&amp;#37; CI: 0.72, 0.97).  Whereas BV at the preceding or current visit was associated with incident HPV, in an alternate model for the outcome of incident BV, HPV at the current, but not preceding, visit was associated with incident BV. Conclusion. These findings underscore the importance of prevention and successful treatment of bacterial vaginosis.</description><Author>Caroline C. King, Denise J. Jamieson, Jeffrey Wiener, Susan Cu-Uvin, Robert S. Klein, Anne M. Rompalo, Keerti V. Shah, and Jack D. Sobel</Author><copyright>Copyright &amp;#xa9; 2011 Caroline C. King et al. All rights reserved.</copyright></item><item><title>Screening for Cytomegalovirus during Pregnancy</title><link>http://www.hindawi.com/journals/idog/2011/942937/</link><description>The epidemiology and pathogenesis of CMV infections among pregnant women have been intensely studied over the last three decades. This paper highlights recent developments that make either universal or limited serologic screening for CMV during pregnancy potentially attractive. The developments include an understanding of the pathogenesis of CMV infections, a knowledge of high-risk women, the availability of accurate methods for the serologic diagnosis of a primary CMV infection using either single or serial blood samples, accurate methods for the diagnosis of fetal infection via amniotic fluid, sensitive fetal and placental indicators for neonatal outcomes, and the availability of potentially effective interventions.</description><Author>Stuart P. Adler</Author><copyright>Copyright &amp;#xa9; 2011 Stuart P. Adler. All rights reserved.</copyright></item><item><title>Chlamydia trachomatis and Mycoplasma genitalium Plasma Antibodies in Relation to Epithelial Ovarian Tumors</title><link>http://www.hindawi.com/journals/idog/2011/824627/</link><description>Objective. To assess associations of Chlamydia trachomatis and Mycoplasma genitalium antibodies with epithelial ovarian tumors. Methods. Plasma samples from 291 women, undergoing surgery due to suspected ovarian pathology, were analyzed with respect to C. trachomatis IgG and IgA, chlamydial Heat Shock Protein 60-1 (cHSP60-1) IgG and M. genitalium IgG antibodies. Women with borderline tumors (n=12), ovarian carcinoma (n=45), or other pelvic malignancies (n=11) were matched to four healthy controls each. Results. Overall, there were no associations of antibodies with EOC. However, chlamydial HSP60-1 IgG antibodies were associated with type II ovarian cancer (P=.002) in women with plasma samples obtained &amp;#x003E;1 year prior to diagnosis (n=7). M. genitalium IgG antibodies were associated with borderline ovarian tumors (P=.01). Conclusion. Chlamydial HSP60-1 IgG and M. genitalium IgG antibodies are in this study associated with epithelial ovarian tumors in some subsets, which support the hypothesis linking upper-genital tract infections and ovarian tumor development.</description><Author>Annika Idahl, Eva Lundin, Margaretha Jurstrand, Urban Kumlin, Fredrik Elgh, Nina Ohlson, and Ulrika Ottander</Author><copyright>Copyright &amp;#xa9; 2011 Annika Idahl et al. All rights reserved.</copyright></item><item><title>High-Risk Human Papillomavirus Is Associated with HIV Acquisition among South African Female Sex Workers</title><link>http://www.hindawi.com/journals/idog/2011/692012/</link><description>Background. Mounting evidence suggests an association between human papillomavirus (HPV) and HIV acquisition. This study aimed to explore this association among South African female sex workers (FSWs). Methods. We used data from 88 HIV-negative FSWs who participated in a vaginal gel (COL-1492) trial. Cervicovaginal rinse samples, obtained before HIV-seroconversion, were genotyped into high-risk (HR-) and low-risk (LR-) HPV. HIV-adjusted hazard ratios (aHRs) and 95&amp;#37; confidence intervals (CI) were estimated using Cox survival analysis. Results. HR- and LR-HPV prevalences were 70.5&amp;#37; (95&amp;#37; CI&amp;#x2009;:&amp;#x2009;60.5&amp;#8211;79.2) and 60.2&amp;#37; (95&amp;#37; CI&amp;#x2009;:&amp;#x2009;49.9&amp;#8211;70.0), respectively. Twenty-five women HIV seroconverted. Controlling for background characteristics and other sexually transmitted infections, HIV aHR increased by a factor of 1.7 (95&amp;#37; CI&amp;#x2009;:&amp;#x2009;1.01&amp;#8211;2.7, Plinear trend = 0.045) for an increase of one unit of the number of HR-HPV genotypes. Conclusions. HIV seroconversion among FSWs is associated with genital HR-HPV infection. Further investigation is warranted, including testing the possible protective effect of available HPV vaccines on HIV acquisition.</description><Author>Bertran Auvert, Dianne Marais, Pascale Lissouba, Kevin Zarca, Gita Ramjee, and Anna-Lise Williamson</Author><copyright>Copyright &amp;#xa9; 2011 Bertran Auvert et al. All rights reserved.</copyright></item><item><title>The Emergence of Clostridium difficile Infection among Peripartum Women: A Case-Control Study of a C. difficile Outbreak on an Obstetrical Service</title><link>http://www.hindawi.com/journals/idog/2011/267249/</link><description>Objective. An outbreak of 20 peripartum Clostridium difficile infections (CDI) occurred on the obstetrical service at the University of Washington Medical Center (UWMC) between April 2006 and June 2007. In this report, we characterize the clinical manifestations, describe interventions that appeared to reduce CDI, and determine potential risk factors for peripartum CDI. Methods. An investigation was initiated after the first three peripartum CDI cases. Based on the findings, enhanced infection control measures and a modified antibiotic regimen were implemented. We conducted a case-control study of peripartum cases and unmatched controls. Results. During the outbreak, there was an overall incidence of 7.5 CDI cases per 1000 deliveries. Peripartum CDI infection compared to controls was significantly associated with cesarean delivery (70&amp;#37; versus 34&amp;#37;; P=0.03
), antibiotic use (95&amp;#37; versus 56&amp;#37;; P=0.001), chorioamnionitis (35&amp;#37; versus 5&amp;#37;; P=0.001), and the use of the combination of ampicillin, gentamicin, and clindamycin (50&amp;#37; versus 3&amp;#37;; P&amp;#x003C;0.001
). Use of combination antibiotics remained a significant independent risk factor for CDI in the multivariate analysis. Conclusions. The outbreak was reduced after the implementation of multiple infection control measures and modification of antibiotic use. However, sporadic CDI continued for 8 months after these measures slowed the outbreak. Peripartum women appear to be another population susceptible to CDI.</description><Author>Jennifer A. Unger, Estella Whimbey, Michael G. Gravett, and David A. Eschenbach</Author><copyright>Copyright &amp;#xa9; 2011 Jennifer A. Unger et al. All rights reserved.</copyright></item><item><title>Histological Chorioamnionitis Is Increased at Extremes of Gestation in Stillbirth: A Population-Based Study</title><link>http://www.hindawi.com/journals/idog/2011/456728/</link><description>Objective. To determine the incidence of histological chorioamnionitis and a fetal response in stillbirths in New South Wales (NSW), and to examine any relationship of fetal response to spontaneous onset of labour and to unexplained antepartum death. Study Design. Population-based cohort study. Setting. New South Wales Australia. Population. All births between 2002 and 2004 with stillbirths reviewed and classified by the state perinatal mortality review committee. Methods. Record linkage of the Midwives Data Collection and the Perinatal Death Database including placental histopathology and standardised cause of death classification. Results. 952 stillbirths were included. The incidence of histopathological chorioamnionitis was 22.6&amp;#37;, with a bimodal distribution. A fetal inflammatory response was present in 10.1&amp;#37; and significantly correlated with spontaneous onset of labour. The absence of a fetal inflammatory response was strongly associated with unexplained antepartum death. Conclusions. The increased incidence of histological chorioamnionitis at extremes of gestation is confirmed in the largest dataset to date using population data. This has important implications for late gestation stillbirth as the percentage of unexplained stillbirths increases near term.</description><Author>Adrienne Gordon, Monica Lahra, Camille Raynes-Greenow, and Heather Jeffery</Author><copyright>Copyright &amp;#xa9; 2011 Adrienne Gordon et al. All rights reserved.</copyright></item><item><title>Chlamydia trachomatis Vaccine Research through the Years</title><link>http://www.hindawi.com/journals/idog/2011/963513/</link><description>Chlamydia trachomatis is a Gram-negative obligate intracellular bacterium. It is the leading cause of bacterial sexual transmitted infections (STIs). World Health Organization figures estimated that over 90 million new cases of genital C. trachomatis infections occur worldwide each year. A vaccination program is considered to be the best approach to reduce the prevalence of C. trachomatis infections, as it would be much cheaper and have a greater impact on controlling C. trachomatis infections worldwide rather than a screening program or treating infections with antibiotics. Currently, there are no vaccines available which effectively protect against a C. trachomatis genital infection despite the many efforts that have been made throughout the years. In this paper, the many attempts to develop a protective vaccine against a genital C. trachomatis infection will be reviewed.</description><Author>Katelijn Schautteet, Evelien De Clercq, and Daisy Vanrompay</Author><copyright>Copyright &amp;#xa9; 2011 Katelijn Schautteet et al. All rights reserved.</copyright></item><item><title>C. trachomatis in Female Reproductive Tract Infections and RFLP-Based Genotyping: A 16-Year Study from a Tertiary Care Hospital</title><link>http://www.hindawi.com/journals/idog/2011/548219/</link><description>Presence of Chlamydia trachomatis in endocervix was determined in 2466 women attending a tertiary care hospital in New Delhi, India over  a period of 16 years, using a  monoclonal-based  direct immunofluorescence assay, tissue culture isolation, and  a conventional PCR assay. Chlamydia antigen could be detected in 391 out of 2466 (15.85&amp;#37;) of patients studied; in  27.27&amp;#37; women  with PID, 16.74&amp;#37; women with cervicitis, 16.03&amp;#37; women with infertility, and 12.06&amp;#37; women with  adverse pregnancy outcomes, respectively. There was a statistically significant decreasing trend in Chlamydia antigen positivity between the years 1994&amp;#8211;1999 and 2000&amp;#8211;2004; the apparent decline in antigen positivity between the years 2000&amp;#8211;2004 and 2005&amp;#8211;2010 was not statistically significant. Antigen detection assay detected equal number of positives as the PCR assay; tissue culture isolation demonstrated lower positivity. In a few representative specimens from cervicitis patients,  genotyping was done using RFLP pattern analysis of C. trachomatis MOMP gene amplified by PCR assay, all of these belonged to Chlamydia trachomatis serovar E.</description><Author>Satpathy Gita, Mittal Suneeta, Sharma Anjana, Nayak Niranjan, Mohanty Sujata, and R. M. Pandey</Author><copyright>Copyright &amp;#xa9; 2011 Satpathy Gita et al. All rights reserved.</copyright></item><item><title>Achieving High Coverage of H1N1 Influenza Vaccine in an Ethnically Diverse Obstetric Population: Success of a Multifaceted Approach</title><link>http://www.hindawi.com/journals/idog/2011/746214/</link><description>Objective. To report on a multifaceted approach to increase uptake of the H1N1 vaccine in our ethnically diverse obstetrical population.  
Methods. A review of our obstetric clinic vaccine registry and the approaches used to increase vaccine uptake. We created a real-time vaccine registry, educated patients in their own language via educational videos and use of cultural case workers, facilitated patient appointments and transportation, educated staff, and used other interventions to enhance immunization uptake. Results. Within the first month of H1N1 availability, we vaccinated 120 of our total 157 obstetrics patients. Our overall coverage rate was 76&amp;#37; (number vaccinated/total number eligible.) Of the enrolled patients, the vaccine acceptance rates were similar in our English (59 (78&amp;#37;) of 76) versus non-English (59 (75&amp;#37;) of 79) speaking patients. Conclusions. High vaccine coverage is possible in an ethnically diverse, highly immigrant obstetrics population.</description><Author>Kara K. Hoppe and Linda O. Eckert</Author><copyright>Copyright &amp;#xa9; 2011 Kara K. Hoppe and Linda O. Eckert. All rights reserved.</copyright></item><item><title>Prevalence and Assessment of Clinical Management of Sexually Transmitted Infections among Female Sex Workers in Two Cities of India</title><link>http://www.hindawi.com/journals/idog/2011/494769/</link><description>Objective. Control of sexually transmitted infections (STIs) among female sex workers (FSWs) is an important strategy to reduce HIV transmission. A study was conducted to determine the prevalence and assess the current clinical management of STIs in India. Methods.  FSWs attending three clinics for regular checkups or symptoms were screened for study eligibility. A behavioral questionnaire was administered, clinical examination performed, and laboratory samples collected. Results. 417 study participants reported a mean number of 4.9 (SD 3.5) commercial clients in the last week. 14.6&amp;#37; reported anal sex in the last three months. Consistent condom use with commercial and regular partners was 70.1&amp;#37; and 17.5&amp;#37;, respectively. The prevalence of gonorrhea was 14.1&amp;#37;, chlamydia 16.1&amp;#37;, and trichomoniasis 31.1&amp;#37; with a third of all infections being asymptomatic. Syphilis seropositivity was 10.1&amp;#37;. Conclusions. At study sites, presumptive treatment for gonorrhea, chlamydia, and syphilis screening should continue. Presumptive treatment for trichomoniasis should be considered. Consistent condom use and partner treatment need to be reemphasized.</description><Author>A. Das, P. Prabhakar, P. Narayanan, G. Neilsen, T. Wi, S. Kumta, G. Rao, R. Gangakhedkar, and A. Risbud</Author><copyright>Copyright &amp;#xa9; 2011 A. Das et al. All rights reserved.</copyright></item><item><title>Leukemia Inhibitory Factor Downregulates Human Papillomavirus-16 Oncogene Expression and Inhibits the Proliferation of Cervical Carcinoma Cells</title><link>http://www.hindawi.com/journals/idog/2011/463081/</link><description>The constitutive proliferation and resistance to differentiation and apoptosis of neoplastic cervical cells depend on sustained expression of human papillomavirus oncogenes.  Inhibition of these oncogenes is a goal for the prevention of progression of HPV-induced neoplasias to cervical cancer. SiHa cervical cancer cells were transfected with an HPV-16 promoter reporter construct and treated with leukemia inhibitory factor (LIF), a human cytokine of the interleukin 6 superfamily. SiHa and CaSki cervical cancer cells were also assessed for proliferation by MTT precipitation, programmed cell death by flow cytometry, and HPV E6 and E7 expression by real-time PCR. LIF-treated cervical cancer cells showed significantly reduced HPV LCR activation, reduced levels of E6 and E7 mRNA, and reduced proliferation. We report the novel use of LIF to inhibit viral oncogene expression in cervical cancer cells, with concomitant reduction in proliferation suggesting re-engagement of cell-cycle regulation.</description><Author>Joseph M. Bay, Bruce K. Patterson, and Nelson N. H. Teng</Author><copyright>Copyright &amp;#xa9; 2011 Joseph M. Bay et al. All rights reserved.</copyright></item><item><title>Chlamydia trachomatis Immune Evasion via  Downregulation of MHC Class I Surface Expression Involves Direct and Indirect Mechanisms</title><link>http://www.hindawi.com/journals/idog/2011/420905/</link><description>Genital C. trachomatis infections typically last for many months in women.  This has been attributed to several strategies by which C. trachomatis evades immune detection, including well-described methods by which C. trachomatis decreases the cell surface expression of the antigen presenting molecules major histocompatibility complex (MHC) class I, MHC class II, and CD1d in infected genital epithelial cells.  We have harnessed new methods that allow for separate evaluation of infected and uninfected cells within a mixed population of chlamydia-infected endocervical epithelial cells to demonstrate that MHC class I downregulation in the presence of C. trachomatis is mediated by direct and indirect (soluble) factors. Such indirect mechanisms may aid in priming surrounding cells for more rapid immune evasion upon pathogen entry and help promote unfettered spread of C. trachomatis genital infections.</description><Author>Joyce A. Ibana, Danny J. Schust, Jun Sugimoto, Takeshi Nagamatsu, Sheila J. Greene, and Alison J. Quayle</Author><copyright>Copyright &amp;#xa9; 2011 Joyce A. Ibana et al. All rights reserved.</copyright></item><item><title>Knowledge of Toxoplasmosis among Doctors and Nurses Who Provide Prenatal Care in an Endemic Region</title><link>http://www.hindawi.com/journals/idog/2011/750484/</link><description>Congenital toxoplasmosis is a potentially severe infection and its prevention is most often based on serological screening in pregnant women. Many cases could be prevented by simple precautions during pregnancy. Aiming to assess the knowledge about toxoplasmosis among professionals working in antenatal care in a high prevalent region, a questionnaire was administered to 118 obstetric nurses and physicians attending at primary care units and hospitals. The questionnaire was self-completed and included questions on diagnosis, clinical issues, and prevention. Only 44&amp;#37; of total answers were corrected. Lower scores were observed among those with over 10 years of graduation, working in primary care units, and nurses. Errors were mainly observed in questions of prevention and diagnosis.  As congenital toxoplasmosis is a mother-to-child (MTC) transmitted disease, early diagnosis and treatment can prevent serious and irreversible fetal damage. Thus, doctors and nurses who provide prenatal care must be appropriately trained on prophylactic, diagnostic, and clinical aspects of toxoplasmosis. The authors suggest that measures should be taken for continuing education regarding toxoplasmosis in pregnancy.</description><Author>Laura Berriel da Silva, Raquel de Vasconcelos Carvalhaes de Oliveira, Marizete Pereira da Silva, Wendy Fernandes Bueno, Maria Regina Reis Amendoeira, and Elizabeth de Souza Neves</Author><copyright>Copyright &amp;#xa9; 2011 Laura Berriel da Silva et al. All rights reserved.</copyright></item><item><title>Chlamydia trachomatis Genotypes and the Swedish New Variant among Urogenital Chlamydia trachomatis Strains in Finland</title><link>http://www.hindawi.com/journals/idog/2011/481890/</link><description>Our aims were to genotype Chlamydia trachomatis strains present in urogenital samples and to investigate the occurrence of the Swedish new variant of C. trachomatis in Finland. We genotyped 160 C. trachomatis positive samples with ompA real-time PCR and analyzed 495 samples for the new variant. The three most prevalent genotypes were E (40%), F (28%), and G (13%). Only two specimens containing bacteria with the variant plasmid were detected. It seems that in Finland the percentage of infections due to genotypes F and G has slightly increased during the last 20 years. Genotypes E and G appear to be more common, and genotypes J/Ja and I/Ia appear to be less common in Europe than in the USA. Although the genotype E was the most common genotype among C. trachomatis strains, the new variant was rarely found in Finland.</description><Author>Suvi Niemi, Eija Hiltunen-Back, and Mirja Puolakkainen</Author><copyright>Copyright &amp;#xa9; 2011 Suvi Niemi et al. All rights reserved.</copyright></item><item><title>Safety and Tolerability of Antiretrovirals during Pregnancy</title><link>http://www.hindawi.com/journals/idog/2011/867674/</link><description>Combination antiretroviral therapy (CART) dramatically decreases mother-to-child HIV-1 transmission (MTCT), but maternal adverse events are not infrequent. A review of 117 locally followed pregnancies revealed 7 grade &amp;#x2265;3 AEs possibly related to antiretrovirals, including 2 hematologic, 3 hepatic, and 2 obstetric cholestasis cases. A fetal demise was attributed to obstetric cholestasis, but no maternal deaths occurred. The drugs possibly associated with these AE were zidovudine, nelfinavir, lopinavir/ritonavir, and indinavir. AE or intolerability required discontinuation/substitution of nevirapine in 16&amp;#x0025; of the users, zidovudine in 10%, nelfinavir in 9%, lopinavir/ritonavir in 1%, but epivir and stavudine in none. In conclusion, nevirapine, zidovudine, and nelfinavir had the highest frequency of AE and/or the lowest tolerability during pregnancy. Although nevirapine and nelfinavir are infrequently used in pregnancy at present, zidovudine is included in most MTCT preventative regimens. Our data emphasize the need to revise the treatment recommendations for pregnant women to include safer and better-tolerated drugs.</description><Author>Adriana Weinberg, Jeri Forster-Harwood, Jill Davies, Elizabeth J. McFarland, Jennifer Pappas, Kay Kinzie, Emily Barr, Suzanne Paul, Carol Salbenblatt, Elizabeth Soda, Anna Vazquez, and Myron J. Levin</Author><copyright>Copyright &amp;#xa9; 2011 Adriana Weinberg et al. All rights reserved.</copyright></item><item><title>HSV Serologic Testing for Pregnant Women: Willingness to Be Tested and Factors Affecting Testing</title><link>http://www.hindawi.com/journals/idog/2011/874820/</link><description>Objective. This prospective study was undertaken to evaluate pregnant women&amp;#39;s willingness to undergo HSV type-specific serologic testing and factors affecting willingness in an obstetrics/gynecology ambulatory unit. Methods. At prenatal Visit 1,  pregnant women (n=303) with no history of HSV-2 were tested for HSV-1/HSV-2  before and after they received counseling on genital and neonatal herpes. Results. In both the Unwilling Subgroup and the group that changed from being willing to being unwilling, the most common reasons for choosing not to be tested were not being at risk for genital herpes, being tested is too personal, and concern about what will be done with the results. Of the 134 participants in the Willing/Tested Subgroup, 27 (20&amp;#37;) were HSV-2 seropositive and 81 (60&amp;#37;) were HSV-1 seropositive. Conclusions. These results support the feasibility of HSV serologic testing and counseling in pregnant women.</description><Author>David A. Baker, Andrea Pressley, Lillian Meek, Reinaldo Figueroa, Barbara Yates, and Lynn Dix</Author><copyright>Copyright &amp;#xa9; 2011 David A. Baker et al. All rights reserved.</copyright></item><item><title>Association of Low-Risk Human Papillomavirus Infection with Male Circumcision in Young Men: Results from a Longitudinal Study Conducted in Orange Farm (South Africa)</title><link>http://www.hindawi.com/journals/idog/2011/567408/</link><description>Background. Low-Risk Human Papillomavirus (LR-HPV) genotypes 6 and 11 cause genital warts. This study investigated the association of LR-HPV infection with male circumcision (MC). Methods. We used data from the South African MC trial conducted among young men. Urethral swabs, collected among intervention (circumcised) and control (uncircumcised) groups, were analyzed using HPV linear array. Adjusted LR-HPV prevalence rate ratio (aPPR) and Poisson mean ratio (aPMR) of number of LR-HPV genotypes were estimated using log-Poisson regression, controlling for background characteristics, sexual behaviour, and HIV and HSV-2 statuses. Results. Compared to controls, LR-HPV prevalence and mean number of genotypes were significantly lower among the intervention group ((8.5&amp;#37; versus 15.8&amp;#37;; aPRR: 0.54, P&amp;#x003C;.001) and (0.33 versus 0.18; aPMR: 0.54, P&amp;#x003C;.001), resp.). Mean number of LR-HPV genotypes increased with number of lifetime sexual partners and decreased with education level and consistent condom use. Conclusions. This study shows a reduction in LR-HPV infection among circumcised men.</description><Author>Chlo&amp;#233; Tarnaud, Pascale Lissouba, Ewalde Cutler, Adrian Puren, Dirk Taljaard, and Bertran Auvert</Author><copyright>Copyright &amp;#xa9; 2011 Chlo&amp;#xe9; Tarnaud et al. All rights reserved.</copyright></item><item><title>Genital HSV Detection among HIV-1-Infected Pregnant Women in Labor</title><link>http://www.hindawi.com/journals/idog/2011/157680/</link><description>Objective. To compare genital HSV shedding among HIV-positive and HIV-negative women. Methods. Women with and without known HIV infection who delivered at the University of Washington Medical Center between 1989&amp;#8211;1996 had HSV serologies done as part of clinical care. Genital swabs from HSV-2-seropositive women were evaluated by real-time quantitative HSV DNA PCR. Results. HSV-2 seroprevalence was 71&amp;#37; and 30&amp;#37; among 75 HIV-positive and 3051 HIV-negative women, respectively, (P&amp;#x003C;.001). HSV was detected at delivery in the genital tract of 30.8&amp;#37; of HIV-seropositive versus 9.5&amp;#37; of HIV-negative women (RR=3.2, 95&amp;#37; CI 1.6 to 6.5, P=.001). The number of virion copies shed per mL was similar (log&amp;#x2009;3.54 for HIV positive versus 3.90 for HIV negative, P=.99). Conclusions. Our study demonstrated that HIV-, HSV-2-coinfected women are more likely to shed HSV at delivery.</description><Author>Janna Patterson, Jane Hitti, Stacy Selke, Meei-Li Huang, D. Heather Watts, Zane Brown, Lawrence Corey, and Anna Wald</Author><copyright>Copyright &amp;#xa9; 2011 Janna Patterson et al. All rights reserved.</copyright></item><item><title>Synlabia after Severe Monilia Infections: A Case Report</title><link>http://www.hindawi.com/journals/idog/2010/209021/</link><description>Case. A 25-year-old woman presented with acute urine retention with overflow 6 months after an inadequate treatment of severe monilia infections. Examination revealed complete adhesion between both labia majora. Division of adhesion was done with reconstruction by labial mucocutaneous flap. Complete recovery was achieved with good cosmetic outcome. Conclusion. Labial adhesions whatever their severity is can be surgically divided with complete correction by locally designed flap to reconstruct the introuitus with rapid recovery, good healing, and good cosmetic outcome.</description><Author>Samia M. A. Saied</Author><copyright>Copyright &amp;#xa9; 2010 Samia M. A. Saied. All rights reserved.</copyright></item><item><title>Obstetrician-Gynecologists and Perinatal Infections: A Review of Studies of the Collaborative Ambulatory Research Network (2005&amp;#8211;2009)</title><link>http://www.hindawi.com/journals/idog/2010/583950/</link><description>Background. Maternal infection is associated with adverse pregnancy outcomes, and ob-gyns are in a unique position to help prevent and treat infections. Methods. This paper summarizes studies completed by the Research Department of the American College of Obstetricians and Gynecologists regarding perinatal infections that were published between 2005 and 2009. Results. Obstetrician-gynecologists are routinely screening for hepatitis B and HIV, and many counsel prenatal patients regarding hepatitis B and toxoplasmosis. However, other infections are not regularly discussed, and many cited time constraints as a barrier to counseling. A majority discusses the transmission of giardiasis and toxoplasmosis, but few knew the source of cryptosporidiosis or cyclosporiasis. Conclusions. Many of the responding ob-gyns were unaware of or not adhering to infection management guidelines. Obstetrician-gynecologists are knowledgeable regarding perinatal infections; however, guidelines must be better disseminated perhaps via a single infection management summary. This paper identified knowledge gaps and areas in which practice can be improved and importantly highlights the need for a comprehensive set of management guidelines for a host of infections, so that physicians can have an easy resource when encountering perinatal infections.</description><Author>Meaghan A. Leddy, Bernard Gonik, and Jay Schulkin</Author><copyright>Copyright &amp;#x00A9; 2010 Meaghan A. Leddy et al. All rights reserved.</copyright></item><item><title>Easiness of Use and Validity Testing of VS-SENSE Device for Detection of Abnormal Vaginal Flora and Bacterial Vaginosis</title><link>http://www.hindawi.com/journals/idog/2010/504972/</link><description>Accessing vaginal pH is fundamental during gynaecological visit for the detection of abnormal vaginal flora (AVF), but use of pH strips may be time-consuming and difficult to interpret. The aim of this study was to evaluate the VS-SENSE test (Common Sense Ltd, Caesarea, Israel) as a tool for the diagnosis of AVF and its correlation with abnormal pH and bacterial vaginosis (BV). The study population consisted of 45 women with vaginal pH &amp;#x2265; 4.5 and 45 women with normal pH. Vaginal samples were evaluated by VS-SENSE test, microscopy and microbiologic cultures. Comparing with pH strips results, VS-SENSE test specificity was 97.8&amp;#37; and sensitivity of 91&amp;#37;. All severe cases of BV and aerobic vaginitis (AV) were detected by the test. Only one case with normal pH had an unclear result. Concluding, VS-SENSE test is easy to perform, and it correlates with increased pH, AVF, and the severe cases of BV and AV.</description><Author>Gilbert G. G. Donders, Camila Marconi, and Gert Bellen</Author><copyright>Copyright &amp;#xa9; 2010 Gilbert G. G. Donders et al. All rights reserved.</copyright></item><item><title>Vaginal Practices of HIV-Negative Zimbabwean Women</title><link>http://www.hindawi.com/journals/idog/2010/387671/</link><description>Background. Vaginal practices (VPs) may increase HIV risk by injuring vaginal epithelium or by increasing risk of bacterial vaginosis, an established risk factor for HIV. Methods. HIV-negative Zimbabwean women (n=2,185) participating in a prospective study on hormonal contraception and HIV risk completed an ancillary questionnaire capturing detailed VP data at quarterly followup visits for two years. Results. Most participants (84&amp;#37;) reported ever cleansing inside the vagina, and at 40&amp;#37; of visits women reported drying the vagina using cloth or paper. Vaginal tightening using cloth/cotton wool, lemon juice, traditional herbs/powders, or other products was reported at 4&amp;#37; of visits. Women with &amp;#x2265;15 unprotected sex acts monthly had higher odds of cleansing (adjusted odds ratio (aOR): 1.17, 95&amp;#37; CI: 1.04&amp;#8211;1.32). Women with sexually transmitted infections had higher odds of tightening (aOR: 1.42, 95&amp;#37; CI: 1.08&amp;#8211;1.86). Conclusion. Because certain vaginal practices were associated with other HIV risk factors, synergism between VPs and other risk factors should be explored.</description><Author>Abigail Norris Turner, Charles S. Morrison, Marshall W. Munjoma, Precious Moyo, Tsungai Chipato, and Janneke H. van de Wijgert</Author><copyright>Copyright &amp;#xa9; 2010 Abigail Norris Turner et al. All rights reserved.</copyright></item><item><title>Elevated Levels of IL-10 and G-CSF Associated with Asymptomatic Malaria in Pregnant Women</title><link>http://www.hindawi.com/journals/idog/2010/317430/</link><description>In sub-Saharan Africa, approximately 30 million pregnant women are at risk of contracting malaria annually. Nearly 36&amp;#37; of healthy pregnant women receiving routine antenatal care tested positive for Plasmodium falciparum HRP-II antigen in Ghana. We tested the hypothesis that asymptomatic HRP II positive pregnant women expressed a unique Th1 and Th2 phenotype that differs from healthy controls. Plasma from healthy (n=15) and asymptomatic (n=25) pregnant women were evaluated for 27 biomarkers (IL-1b, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL- 17, Eotaxin, bFGF-2, G-CSF, GM-CSF, IFN-&amp;#x03B3;, IP-10, MCP-1, MIP-1&amp;#x03B1;, MIP-1&amp;#x03B2;, PDGF-bb, RANTES, TNF, and VEGF) associated with Th1 and Th2 cytokine homeostasis. IL-10 and G-CSF levels were elevated in the asymptomatic group when compared with the healthy group (P=.031 and .041, resp.). The median ratios of IL-1&amp;#x03B2;:5, IL-1&amp;#x03B2;:10, IL-1&amp;#x03B2;:G-CSF, IL-1&amp;#x03B2;:Eotaxin, IL-12:G-CSF, IL-15:10, IL-17:G-CSF, IL-17:Eotaxin, TNF:IL-4, TNF:IL-5, and TNF:G-CSF were significantly different among the two groups. Thus, asymptomatic malaria carriage may be linked to circulating levels of IL-10 and G-CSF.</description><Author>Nana O. Wilson, Tameka Bythwood, Wesley Solomon, Pauline Jolly, Nelly Yatich, Yi Jiang, Faisal Shuaib, Andrew A. Adjei, Winston Anderson, and Jonathan K. Stiles</Author><copyright>Copyright &amp;#x00A9; 2010 Nana O. Wilson et al. All rights reserved.</copyright></item><item><title>Prevalence and Risk Factors of Sexually Transmitted Infections and Cervical Neoplasia in Women from a Rural Area of Southern Mozambique</title><link>http://www.hindawi.com/journals/idog/2010/609315/</link><description>There is limited information on the prevalence of sexually transmitted infections and the prevalence of cervical neoplasia in rural sub-Saharan Africa. This study describes the prevalence and the etiology of STIs and the prevalence of cervical neoplasia among women in southern Mozambique. 
An age-stratified cross-sectional study was performed where 262 women aged 14 to 61 years were recruited at the antenatal clinic (59&amp;#37;), the family-planning clinic (7&amp;#37;), and from the community (34&amp;#37;). 
At least one active STI was diagnosed in 79&amp;#37; of women. Trichomonas vaginalis was present in 31&amp;#37; of all study participants. The prevalence of Neisseria gonorrhea and Chlamydia trachomatis were 14&amp;#37; and 8&amp;#37;, respectively, and Syphilis was diagnosed in 12&amp;#37; of women. HPV DNA was detected in 40&amp;#37; of women and cervical neoplasia was diagnosed in 12&amp;#37; of all women.
Risk factors associated with the presence of some of the STIs were being divorced or widowed, having more than one sexual partner and having the partner living in another area. A higher prevalence was observed in the reproductive age group and some of the STIs were more frequently diagnosed in pregnant women. STI control programs are a priority to reduce the STIs burden, including HIV and cervical neoplasia.</description><Author>Clara Men&amp;#233;ndez, Xavier Castellsagu&amp;#233;, Montse Renom, Jahit Sacarlal, Lloren&amp;#231; Quint&amp;#243;, Belen Lloveras, Joellen Klaustermeier, Janet R. Kornegay, Betuel Sigauque, F. Xavier Bosch, and Pedro L. Alonso</Author><copyright>Copyright &amp;#x00A9; 2010 Clara Men&amp;#233;ndez et al. All rights reserved.</copyright></item></channel></rss>
